Dachille Douglas A.
- SEC CIK
- 0001652908
No open-market purchases or sales filed in the past year.
Current role at each company
- PNC PNC Financial Services Group, Inc.Directoras of Jul 6, 2026
- BBIO BridgeBio Pharma, Inc.Directoras of Jun 24, 2026
- EQH Equitable Holdings, Inc.Directoras of May 21, 2026
- AIG American International Group, Inc.EVP and CIOas of Jul 1, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Dachille Douglas A. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PNC PNC Financial Services Group, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 5, 2025 (view filing) | Feb 3 | 2 days | Dachille Douglas A.Director | PPurchase$5 Par Common Stock | +100 | $198.13 | +$19.8K | New position100 after |
BBIO BridgeBio Pharma, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2022 (view filing) | Mar 14 | 2 days | Dachille Douglas A.Director | PPurchase | +10.0K | $8.19 | +$81.9K | +100.0%20.0K after | |
| Jan 6, 2022 (view filing) | Jan 4-5 | 2 days | Dachille Douglas A.Director | PPurchase | +10.0K | $16.37 | +$163.7K | New position10.0K after | 2 lots |